Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.72% is 18% above its 5-year average of 1.46%, around the middle of its 5-year range (-26.87%–29.40%).
As of the fiscal period ended Wednesday, December 31, 2025. 127.50% above its 12-month average of -6.26%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
1.72%
RETURN ON ASSETS (ROA) AVG TTM
-6.26%
RETURN ON ASSETS (ROA) AVG 3Y
-11.14%
RETURN ON ASSETS (ROA) AVG 5Y
1.46%
RETURN ON ASSETS (ROA) AVG 10Y
3.96%
RETURN ON ASSETS (ROA) AVG 15Y
4.18%
RETURN ON ASSETS (ROA) AVG 20Y
4.58%
CURRENT VS TTM AVG
+127.50%
CURRENT VS 3Y AVG
+115.44%
CURRENT VS 5Y AVG
+18.08%
CURRENT VS 10Y AVG
-56.61%
CURRENT VS 15Y AVG
-58.82%
CURRENT VS 20Y AVG
-62.48%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-65.11%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$8.50B
Return on Assets (ROA)
1.72%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$7.47B
Return on Assets (ROA)
-14.19%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$7.31B
Return on Assets (ROA)
-0.42%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$9.74B
Return on Assets (ROA)
3.49%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$9.75B
Return on Assets (ROA)
9.70%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$10.31B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.37B
Return on Assets (ROA)
-9.07%
TTM Avg
-6.92%
3Y Avg
-1.48%
5Y Avg
0.07%
Market Cap
$6.27B
Return on Assets (ROA)
-0.58%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$10.91B
Return on Assets (ROA)
-2.39%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.50B | 1.72% | -6.26% | -11.14% | 1.46% |
| Tempus AI, Inc. (TEM)vs › | $7.47B | -14.19% | -43.49% | -42.71% | -41.26% |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | -0.42% | -3.24% | -6.85% | -10.42% |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 3.49% | 3.68% | 4.39% | 5.01% |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 9.70% | 8.61% | 6.84% | 6.99% |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | -0.04% | 5.29% | 6.08% | 6.13% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.27B | -0.58% | 11.88% | 0.12% | -6.73% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | -2.39% | -0.94% | 2.58% | 3.75% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 4.30% | 4.54% | 7.94% | 8.21% |
ROA
1.7%
ROE
2.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.18% |
| 2024-12-31 | -19.69% |
| 2023-12-31 | -5.18% |
| 2022-12-31 | -26.87% |
| 2021-12-31 | 23.90% |
| 2020-12-31 | 29.40% |
| 2019-12-31 | 21.96% |
| 2018-12-31 | 6.43% |
| 2017-12-31 | 2.69% |
| 2016-12-31 | 0.73% |
| 2015-12-31 | 3.05% |
| 2014-12-31 | 2.66% |
| 2013-12-31 | 2.30% |
| 2012-12-31 | 4.91% |
| 2011-12-31 | 5.76% |
| 2010-12-31 | 6.06% |
| 2009-12-31 | 5.70% |
| 2008-12-31 | 4.39% |
| 2007-12-31 | 4.72% |
| 2006-12-31 | 6.47% |
| 2005-12-31 | 5.72% |
| 2004-12-31 | 4.98% |
| 2003-12-31 | 7.67% |
| 2002-12-31 | 9.42% |
| 2001-12-31 | 6.46% |
| 2000-12-31 | 4.81% |
| 1999-12-31 | 1.75% |
| 1998-12-31 | 6.62% |
| 1997-12-31 | 4.66% |
| 1996-12-31 | 9.20% |
